Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin in Rheumatoid Arthritis Patients Treated with Methotrexate
NCT06724952Phase 4Not yet recruiting
- Sponsor
- Tanta University
- Start
- Dec 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of silymarin in rheumatoid arthritis (RA), sponsored by Tanta University. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
silymarin
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06724952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06724952.